Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Auris Medical

(NASDAQ: EARS)
Add to Portfolio
-0.03 (-1.55%)
as of Oct 18, 2019

Last 1.90
Change -0.03 (-1.55%)
Open 1.94
Prev. Close 1.93
Today's Range
1.86
1.95
52wk Range
1.85
24.80
Volume 42,300
Avg Volume 133,265
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
EARS -1.55% -31.65% -88.82%
DJIA -0.95% +1.49% +5.48%
S&P 500 -0.39% +1.64% +7.85%

Key Statistics

Annual EPS -21.80
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 3,690
Weighted Alpha -87.50
Standard Deviation -0.35
Profit Margin N/A
Beta -0.48

Growth Rates

YTD -79.17%
1-Year -90.10%
3-Year -99.28%
5-Year -99.79%

Opinion

Sell Hold Buy

Recent Headlines

Auris Medical Announces Positive Interim Results from

GlobeNewswire via COMTEX - Fri Oct 11, 08:30AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced positive inte(full story)
EARS: 1.90 (-0.03)

Auris Medical Receives FDA and EMA Guidance for

GlobeNewswire via COMTEX - Fri Sep 13, 09:00AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has o(full story)
EARS: 1.90 (-0.03)

Auris Medical Announces Appointment of New Chief

GlobeNewswire via COMTEX - Wed Sep 04, 07:13AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the appointme(full story)
EARS: 1.90 (-0.03)

Auris Medical Announces Formation of Scientific

GlobeNewswire via COMTEX - Mon Aug 26, 09:00AM EDT
Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the formation(full story)
EARS: 1.90 (-0.03)

New Strong Sell Stocks for August 23rd

ZACKS - Fri Aug 23, 10:21AM EDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.(full story)
SHEN: 30.77 (-0.62), HAFC: 18.39 (+0.02), SSD: 72.38 (-0.17), ACY: 5.30 (-0.11), EARS: 1.90 (-0.03)